Regen BioPharma Inc (RGBP)
0.085
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Regen BioPharma Enterprise Value: 1.424M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.424M |
| November 21, 2024 | 1.393M |
| November 20, 2024 | 1.379M |
| November 19, 2024 | 1.559M |
| November 18, 2024 | 1.351M |
| November 15, 2024 | 1.350M |
| November 14, 2024 | 1.515M |
| November 13, 2024 | 1.479M |
| November 12, 2024 | 1.469M |
| November 11, 2024 | 1.469M |
| November 08, 2024 | 1.559M |
| November 07, 2024 | 1.830M |
| November 06, 2024 | 1.902M |
| November 05, 2024 | 1.918M |
| November 04, 2024 | 2.017M |
| November 01, 2024 | 1.699M |
| October 31, 2024 | 2.731M |
| October 30, 2024 | 2.731M |
| October 29, 2024 | 2.597M |
| October 28, 2024 | 2.755M |
| October 25, 2024 | 2.10M |
| October 24, 2024 | 2.005M |
| October 23, 2024 | 1.654M |
| October 22, 2024 | 2.686M |
| October 21, 2024 | 2.776M |
| Date | Value |
|---|---|
| October 18, 2024 | 2.861M |
| October 17, 2024 | 2.055M |
| October 16, 2024 | 2.064M |
| October 15, 2024 | 2.122M |
| October 14, 2024 | 2.122M |
| October 11, 2024 | 1.739M |
| October 10, 2024 | 1.469M |
| October 09, 2024 | 1.642M |
| October 08, 2024 | 2.10M |
| October 07, 2024 | 2.10M |
| October 04, 2024 | 2.045M |
| October 03, 2024 | 2.097M |
| October 02, 2024 | 1.920M |
| October 01, 2024 | 1.920M |
| September 30, 2024 | 1.583M |
| September 27, 2024 | 1.560M |
| September 26, 2024 | 1.649M |
| September 25, 2024 | 1.402M |
| September 24, 2024 | 1.874M |
| September 23, 2024 | 2.001M |
| September 20, 2024 | 2.009M |
| September 19, 2024 | 1.243M |
| September 18, 2024 | 1.322M |
| September 17, 2024 | 1.556M |
| September 16, 2024 | 1.774M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.243M
Minimum
Sep 19 2024
265.53M
Maximum
Aug 27 2021
23.65M
Average
6.494M
Median
Jul 24 2023
Enterprise Value Benchmarks
| Aethlon Medical Inc | -1.214M |
| AIM ImmunoTech Inc | 8.915M |
| Perspective Therapeutics Inc | -31.63M |
| Protalix BioTherapeutics Inc | 97.03M |
| Armata Pharmaceuticals Inc | 171.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1171M |
| Revenue (Quarterly) | 0.0591M |
| Total Expenses (Quarterly) | 0.167M |
| EPS Diluted (Quarterly) | -0.015 |
| Profit Margin (Quarterly) | -198.3% |
| Earnings Yield | -152.9% |
| Normalized Earnings Yield | -119.40 |